These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14753580)

  • 1. Achieving 95% uptake in an immunisation programme--not an impossibility.
    Joyce-Cooney J; Meagher G; Quinn C; Cavanagh I
    Ir Med J; 2003 Oct; 96(9):268-70. PubMed ID: 14753580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors underlying suboptimal childhood immunisation.
    Tickner S; Leman PJ; Woodcock A
    Vaccine; 2006 Nov; 24(49-50):7030-6. PubMed ID: 16890330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R; Svensson E; Trollfors B; Borres MP
    Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunisation coordinator: improving uptake of childhood immunisation.
    Crittenden P; Rao M
    Commun Dis Rep CDR Rev; 1994 Jun; 4(7):R79-81. PubMed ID: 7520803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium.
    Theeten H; Vandermeulen C; Roelants M; Hoppenbrouwers K; Depoorter AM; Van Damme P
    Acta Paediatr; 2009 Aug; 98(8):1307-12. PubMed ID: 19432835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccination of young children, at school entrance and completion in the Bern canton 1998].
    Maurer AM; Mühlemann K; Seiler AJ
    Praxis (Bern 1994); 2001 Sep; 90(39):1676-84. PubMed ID: 11680120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of a school entry law on adolescent immunization rates.
    Wilson TR; Fishbein DB; Ellis PA; Edlavitch SA
    J Adolesc Health; 2005 Dec; 37(6):511-6. PubMed ID: 16310129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles immunization in Saudi Arabia: the need for change.
    Khalil MK; Al-Mazrou YY; Al-Jeffri M; Al-Ghamdy YS
    East Mediterr Health J; 2001; 7(4-5):829-34. PubMed ID: 15332786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Göppingen 1999 vaccination program in the 5th and 6th grade].
    Oettinger B; Gröber U; Ernst E
    Gesundheitswesen; 2000 Oct; 62(10):505-10. PubMed ID: 11103561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunisation coverage in children with cerebral palsy compared with the general population.
    Greenwood VJ; Crawford NW; Walstab JE; Reddihough DS
    J Paediatr Child Health; 2013 Feb; 49(2):E137-41. PubMed ID: 23360148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
    Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
    Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 years.
    Marshall H; Nolan T; Roberton D; Richmond P; Lambert S; Jacquet JM; Schuerman L
    Vaccine; 2006 Aug; 24(35-36):6120-8. PubMed ID: 16822597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination vaccine use and vaccination quality in a managed care population.
    Happe LE; Lunacsek OE; Marshall GS; Lewis T; Spencer S
    Am J Manag Care; 2007 Sep; 13(9):506-12. PubMed ID: 17803364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination coverage among children in kindergarten--United States, 2006-07 school year.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Aug; 56(32):819-21. PubMed ID: 17703172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resumption of routine schedule for diphtheria and tetanus toxoids and acellular pertussis vaccine and for measles, mumps, and rubella vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jul; 51(27):598-9. PubMed ID: 12143834
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months.
    Usonis V; Meriste S; Bakasenas V; Lutsar I; Collard F; Stoffel M; Tornieporth N
    Vaccine; 2005 Apr; 23(20):2602-6. PubMed ID: 15780442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Dylag AM; Shah SI
    Pediatrics; 2008 Sep; 122(3):e550-5. PubMed ID: 18762489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chickenpox: sufficient reasons for the introduction of vaccination].
    Rümke H; de Groot R
    Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2630-2. PubMed ID: 17205937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.